July 07, 2009 02:01 AM Eastern Daylight Time
BUSINESS WIRE
CBP501 Enters Phase II Trials for the Treatment of Non-Small Cell Lung Cancer
Tweet
View Full Size
Download
Thumbnail
JPEG
,
120
x
40
,
5.0 KB
Preview
JPEG
,
144
x
49
,
7.3 KB
Small
JPEG
,
300
x
102
,
20.8 KB
Full Size
JPEG
,
944
x
323
,
91.9 KB
Smart Multimedia Gallery
http://www.takeda.com
View and Share Graphic
Download Small
Download Full Size
http://www.canbas.co.jp
View and Share Graphic
Download Small
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
All News
|
News with Multimedia
>
News Release: CBP501 Enters Phase II Trials for the Treatment...
Get Business Wire News on Your Website
Terms of Use
|
©2012 Business Wire
Better Be Business Wired.
Business Wire
is the leading source for
press releases
, photos, multimedia and
regulatory filings
from companies and groups throughout the world.